Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by Charite University, Berlin, Germany
Sponsor:
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
JSehouli, Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT01600573
First received: May 9, 2012
Last updated: February 17, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2017
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)